Revenue
No reported data
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | ¥3.8M | ¥1.0M | ¥1.8M | ¥760,465 | ¥1.6M | ¥10.0M | ¥2.4M | ¥1.4M | ¥4.8M | ¥8.5M |
| Operating expenses | ¥67.1M | ¥187.3M | ¥121.5M | ¥85.9M | ¥100.5M | ¥124.0M | ¥182.7M | ¥113.6M | ¥897.6M | ¥467.9M |
| Operating income | −¥182.8M | −¥399.8M | −¥381.3M | −¥338.6M | −¥380.9M | — | — | — | — | — |
| EBITDAderived | −¥166.8M | −¥388.3M | −¥379.6M | −¥336.3M | −¥377.1M | — | — | — | — | — |
| Net income | −¥470.4M | ¥37.8M | ¥164.6M | ¥135.4M | ¥65.2M | ¥114.9M | ¥534.6M | ¥860.9M | ¥532.7M | ¥235.4M |
| Basic EPSper diluted share | — | — | CN¥0.12 | CN¥0.10 | CN¥0.05 | CN¥0.08 | CN¥0.39 | CN¥0.69 | CN¥0.43 | CN¥0.19 |
| Diluted EPSper diluted share | — | — | CN¥0.11 | CN¥0.09 | CN¥0.05 | CN¥0.08 | CN¥0.36 | CN¥0.62 | CN¥0.40 | CN¥0.19 |